GlassScriptPhysician profile
Seth J Koenig
NPI 1255467783
$37,508.18
in general payments reported to CMS, 2019-2025
32 companies · $1,688 in 2025
The $1,688 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,008 · 2020: $4,234 · 2021: $2,700 · 2022: $18K · 2023: $1,398 · 2024: $1,866 · 2025: $1,688.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,953.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,953.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fujifilm Sonosite, INC. | $23,870.27 | 2019-2022 | |
| Cook Incorporated | $7,535.08 | 2019-2020 | |
| Glaxosmithkline, LLC. | $1,204.11 | 2022-2025 | Trelegy Ellipta, Nucala |
| Cook Medical LLC | $1,024.80 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $913.51 | 2023-2025 | Fasenra, Airsupra, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $444.17 | 2023-2025 | Ofev, Stiolto Respimat, Spiriva Respimat |
| Ani Pharmaceuticals, INC. | $310.00 | 2023-2024 | Purified Cortrophin Gel |
| Baxter Healthcare | $236.31 | 2023-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Monarch Airway Clearance System |
| Genzyme Corporation | $235.78 | 2023-2025 | |
| Mylan Specialty L.P. | $230.55 | 2023-2024 | Yupelri |
| Grifols USA, LLC | $168.44 | 2023-2025 | Prolastin-C Liquid |
| Insmed, INC. | $157.77 | 2024-2025 | Arikayce, Brinsupri |
| Regeneron Healthcare Solutions, INC. | $142.33 | 2023-2025 | Dupixent |
| Abbott Laboratories | $125.11 | 2025 | Cardiomems |
| Takeda Pharmaceuticals U.S.A., INC. | $122.53 | 2023-2025 | Aralast, Cuvitru, Hyqvia |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $113.05 | 2023-2025 | Wakix |
| Electromed, INC. | $90.59 | 2023-2024 | Smartvest |
| Vifor Pharma, INC. | $85.82 | 2024-2025 | Zemaira |
| Verona Pharma, INC. | $84.38 | 2025 | Ohtuvayre |
| Lilly USA, LLC | $79.14 | 2023-2025 | Jardiance, Zepbound |
| Viatris Specialty LLC | $72.26 | 2025 | Yupelri |
| Actelion Pharmaceuticals US, INC. | $41.41 | 2025 | Uptravi |
| Amgen INC. | $41.08 | 2024-2025 | Tepezza, Tezspire |
| Corcept Therapeutics | $25.36 | 2023 | Korlym |
| Jazz Pharmaceuticals INC. | $22.22 | 2023 | |
| Dexcom, INC. | $21.76 | 2023 | Dexcom G6 Transmitter |
| Tandem Diabetes Care, INC. | $21.72 | 2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Philips North America LLC | $20.41 | 2023 | |
| Phadia US INC. | $18.95 | 2025 | Immunocap |
| Xeris Pharmaceuticals, INC. | $17.37 | 2025 | Recorlev |
| Sanofi-Aventis U.S. LLC | $16.14 | 2024 | |
| Merck Sharp & Dohme LLC | $15.76 | 2024 | Keytruda |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seth Koenig listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.